Centessa Pharmaceuticals plc ADR (NASDAQ:CNTA) shares, rose in value on Friday, March 28, with the stock price up by 0.55% to the previous day’s close as strong demand from buyers drove the stock to $14.59.
Actively observing the price movement in the last trading, the stock closed the session at $14.51, falling within a range of $14.375 and $15.04. The value of beta (5-year monthly) was 1.548. Referring to stock’s 52-week performance, its high was $19.09, and the low was $7.75. On the whole, CNTA has fluctuated by -3.12% over the past month.
With the market capitalization of Centessa Pharmaceuticals plc ADR currently standing at about $1.94 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-23.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CNTA’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of CNTA currently trading nearly -9.73% and -11.21% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.85, while the 7-day volatility ratio is showing 7.25% which for the 30-day chart, stands at 7.07%. Furthermore, Centessa Pharmaceuticals plc ADR (CNTA)’s beta value is 1.54, and its average true range (ATR) is 1.11.
A comparison of Centessa Pharmaceuticals plc ADR (CNTA) with its peers suggests the former has fared considerably weaker in the market. CNTA showed an intraday change of 0.55% in last session, and over the past year, it grew by 35.59%%.
Data on historical trading for Centessa Pharmaceuticals plc ADR (NASDAQ:CNTA) indicates that the trading volumes over the past 10 days have averaged 1.03 and over the past 3 months, they’ve averaged 887.30K. According to company’s latest data on outstanding shares, there are 132.63 million shares outstanding.
Nearly 39.43% of Centessa Pharmaceuticals plc ADR’s shares belong to company insiders and institutional investors own 54.79% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.86 million shares as on 2025-03-14, resulting in a short ratio of 4.53. According to the data, the short interest in Centessa Pharmaceuticals plc ADR (CNTA) stood at 432.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 4.15 million. The stock has fallen by -12.90% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CNTA stock heading into the next quarter.
